Exact Mass: 365.1699108

Exact Mass Matches: 365.1699108

Found 19 metabolites which its exact mass value is equals to given mass value 365.1699108, within given mass tolerance error 6.4E-8 dalton. Try search metabolite list with more accurate mass tolerance error 1.28E-8 dalton.

Isopentenyladenine-9-N-glucoside

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{6-[(3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxane-3,4,5-triol

C16H23N5O5 (365.1699108)


Isopentenyladenine-9-N-glucoside belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Isopentenyladenine-9-N-glucoside is a strong basic compound (based on its pKa). Isopentenyladenine-9-N-glucoside is produced when isopentenyladenine and UDP-D-glucose react, with UDP as a byproduct. The reaction is catalyzed by UDP glycosyltransferases. Isopentenyladenine-9-N-glucoside is produced when isopentenyladenine and UDP-D-glucose react, with UDP as a byproduct. The reaction is catalyzed by UDP glycosyltransferases. [HMDB]

   

N6-isopentenyladenine-9-glucoside (iP9G)

N6-isopentenyladenine-9-glucoside (iP9G)

C16H23N5O5 (365.1699108)


   

N6-isopentenyladenine-7-glucoside (iP7G)

N6-isopentenyladenine-7-glucoside (iP7G)

C16H23N5O5 (365.1699108)


   

Antibiotic KF 77AG6|B,HCl-Antibiotic KF 77AG6

Antibiotic KF 77AG6|B,HCl-Antibiotic KF 77AG6

C16H23N5O5 (365.1699108)


   

1-methylzeatine riboside|6-(4-hydroxy-1,3-dimethylbut-trans-2-enylamino)-9-beta-D-ribofuranosylpurine

1-methylzeatine riboside|6-(4-hydroxy-1,3-dimethylbut-trans-2-enylamino)-9-beta-D-ribofuranosylpurine

C16H23N5O5 (365.1699108)


   

Isopentenyl-Adenine-9-glucoside

Isopentenyl-Adenine-9-glucoside

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Isopentenyl-Adenine-7-glucoside

Isopentenyl-Adenine-7-glucoside

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

isopentenyl-Adenine-7-glucoside-[d6]

isopentenyl-Adenine-7-glucoside-[d6]

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

isopentenyl-Adenine-9-glucoside-[d6]

isopentenyl-Adenine-9-glucoside-[d6]

C16H23N5O5 (365.1699108)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

N6-Isopentenyladenine-7-glucoside

N6-Isopentenyladenine-7-glucoside

C16H23N5O5 (365.1699108)


   

N6-Isopentenyladenine-9-glucoside

N6-Isopentenyladenine-9-glucoside

C16H23N5O5 (365.1699108)


   
   
   

Isopentenyladenine-9-N-glucoside

Isopentenyladenine-9-N-glucoside

C16H23N5O5 (365.1699108)


   

7-(alpha-D-glucosyl)-N(6)-isopentenyladenine

7-(alpha-D-glucosyl)-N(6)-isopentenyladenine

C16H23N5O5 (365.1699108)


A glucosyl-N(6)-isopentenyladenine in which the glucosyl moiety is in the pyranose form, has alpha-D-configuration and is located at position N-7.

   

(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoylamino]-5-(diaminomethylideneamino)pentanoic acid

(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoylamino]-5-(diaminomethylideneamino)pentanoic acid

C16H23N5O5 (365.1699108)


   

(2s,3s,4r,5s,6r)-2-(hydroxymethyl)-6-{6-[(3-methylbut-2-en-1-yl)amino]purin-9-yl}oxane-3,4,5-triol

(2s,3s,4r,5s,6r)-2-(hydroxymethyl)-6-{6-[(3-methylbut-2-en-1-yl)amino]purin-9-yl}oxane-3,4,5-triol

C16H23N5O5 (365.1699108)


   

(2r,3r,4s,5r)-2-(6-{[(2r,3e)-5-hydroxy-4-methylpent-3-en-2-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-(6-{[(2r,3e)-5-hydroxy-4-methylpent-3-en-2-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O5 (365.1699108)


   

2-{6-[(5-hydroxy-4-methylpent-3-en-2-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

2-{6-[(5-hydroxy-4-methylpent-3-en-2-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O5 (365.1699108)